You are here

Home » Content

Nozokomiyal Kandidemi: İki Olgu Sunumu

Nosocomial candidemia : two case report

Journal Name:

  • İnönü Üniversitesi Tıp Fakültesi Dergisi

Publication Year:

  • 1997

Key Words:

Keywords (Original Language):

Author NameUniversity of AuthorFaculty of Author
Abstract (2. Language): 
Two cases with candidemia were presented in this report. First case had trauma, second case had diabetes mellitus (DM) + chronic renal failure (KBY). Patients were not neutropenic. Fungemia resulted from the infection with Candida spp rather than C. albicans in both patients. Patients could not respond to fluconazole and liposomal amphotericin-B (LAMPH-B) was administered. First case recovered whereas second case died. [Journal of Turgut Özal Medical Center 1997;4(1):103-106]
Bookmark/Search this post with
Abstract (Original Language): 
Bu raporda iki kandidemi olgusu sunuldu. Birinci olgu travmalı, ikinci olgu diabetes mellitus (DM) + kronik böbrek yetmezliği (KBY) bulunan hasta idi. Hastalar nötropenik değildi. Her iki hastada Candida albicans dışı türler ile fungemi gelişti. Hastalarda flukonazol tedavisine yanıt alınamadı ve lipozomal amfoterisin-B (LAMPH-B) tedavisine geçildi. Birinci olgu düzeldi, ikinci olgu kaybedildi. [Turgut Özal Tıp Merkezi Dergisi 1997;4(1):103-106]
FULL TEXT (PDF): 
PDF icon arastirmax-nozokomiyal-kandidemi-iki-olgu-sunumu.pdf
  • 1
103-106
  • Turkish

REFERENCES

References: 

1. Pfaller MA. Nosocomial candidiasis: Emergency species, reservoirs and modes of transmission . Clin Infect Dis 1996; 2: 89-94.
2. John ED Jr. Candida species. In: Mandell GL, Bennett JE, Dolin R (eds). Infectious Diseases. New York, Edinburgh, London : Churchill Livingstone 1995; 2289-306.
3. Bross J, Talbot GH, Maisl G, et al. Risk factors for nosocomial candidemia: a case control study in adult without lukemia. AM J Med 1989; 87: 614-20.
4. Debusk CH, Daoud R, Thirumoorthi MC, et al. Candidemia: current epidemiologic characteristics and a long-therm follow-up of the survivors. Scand J Infect Dis 1994; 26
(6):697-703.
5. Wenzel RP. Nosocomial candidemia: risk factors and
attributable mortality. Clin Infect Dis 1995; 20(6):1531-4.
6. Enweani IB, Ogbonna CI, Kozak W. The incidence of candidiasis amongst the asymptomatic female students of the University of Nigeria. Mycopathologia 1987;99(3):
135-41.
7. Kremeni UJ, Koza I, Hornikova M. Fluconasole in the treatment of mycotic orofaringeal stomatitis and eosophagitis in neutropenic cancer patients. Chemotherapy
1991; 35(5):343-5.
8. Pavlik B, Jod Lowska J. The role of Candida pseudotropicalis in reproductive tract infections. Med Dosw Microbiol 1992: 44(1-2) 83-7.
9. Bialasiewicz O, Kurnatowka A, Smiech-Lomhouska G. Characteristics of fungi and attempts of their elimination from the oral cavity in children treated with orthodontic
applians. Poland Med Dosw Microbiol 1993; 45 (3): 89¬92.
10. Pfaller M, Cabezudo I, Koontz F. Predictive value of surveillance cultures for systemic infection due to candida species. Eur J Clin Microbiol 1987; 6(6) 628-33.
11. Krause W, Matheis H, Wulf K. Fungemia and funguria after oral administration of C. albicans. Lancet 1979; 1:598-9.
12. Stone HH, Kolb LD, Currie CA. Candida sepsis: pathogenesis and principles of treatment. Ann Fung 1974;
697-711.
13. Blumberg EA, Reboli AC. Failure of systemic empirical treatment with Amphotericin B to prevent Candidemia
in neutropenic patients with cancer. J Infect Dis 1996; 22:
462-6.
14. Edwards JE, Filler SG. Current strategies for treating invasive candidiasis: emphasis on infections in nonneutropenic patients. Clin Infect Dis 1992; 14(1): 106¬13.

Thank you for copying data from http://www.arastirmax.com